MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AxoGen Total Current Liabilities 2011-2026 | AXGN
Annual Total Current Liabilities AxoGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.6 M | 30.6 M | 30.4 M | 23.8 M | 24.3 M | 22.8 M | 20.9 M | 13 M | 13.7 M | 11.1 M | 3.71 M | 2.45 M | 2.1 M | 1.48 M | 2.02 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.6 M | 1.48 M | 15.1 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
43 M | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 39.03 | -0.61 % | $ 5.82 K | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
219 M | $ 8.1 | 3.58 % | $ 582 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 9.61 | 2.23 % | $ 1.3 B | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 4.1 | 2.76 % | $ 153 M |  France |
 |
Electromed
ELMD
|
10.5 M | $ 24.46 | 2.02 % | $ 207 M | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 43.13 | -0.43 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.54 | 0.22 % | $ 122 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Apyx Medical Corporation
APYX
|
12.7 M | $ 3.29 | 3.78 % | $ 114 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
193 M | $ 0.52 | -0.99 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.79 | -1.19 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
2.04 B | $ 182.25 | -0.21 % | $ 13.6 B | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
56.2 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.01 | 8.38 % | $ 849 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
16.5 B | $ 113.33 | -0.22 % | $ 197 B | USA |
 |
NuVasive
NUVA
|
716 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
103 M | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 72.95 | -1.22 % | $ 108 B | USA |
 |
InMode Ltd.
INMD
|
70.7 M | $ 13.55 | -0.37 % | $ 876 M | Israel |
 |
IRIDEX Corporation
IRIX
|
13 M | $ 1.43 | - | $ 23.1 M | USA |
 |
IRadimed Corporation
IRMD
|
8.51 M | $ 105.71 | 1.36 % | $ 1.34 B | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.27 | 14.65 % | $ 1.38 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 13.13 | 0.84 % | $ 1.97 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 85.6 | 0.39 % | $ 50.1 B | USA |